134 related articles for article (PubMed ID: 1495737)
1. Serous carcinoma of the peritoneum after oophorectomy.
Weber AM; Hewett WJ; Gajewski WH; Curry SL
Obstet Gynecol; 1992 Sep; 80(3 Pt 2):558-60. PubMed ID: 1495737
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
3. Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry.
Piver MS; Jishi MF; Tsukada Y; Nava G
Cancer; 1993 May; 71(9):2751-5. PubMed ID: 8467455
[TBL] [Abstract][Full Text] [Related]
4. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
5. Papillary intraperitoneal neoplasia resembling ovarian carcinoma after removal of benign ovaries.
White CD
W V Med J; 1993 Jul; 89(7):282-3. PubMed ID: 8351900
[TBL] [Abstract][Full Text] [Related]
6. Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer.
Meiser B; Butow P; Barratt A; Friedlander M; Gattas M; Kirk J; Suthers G; Walpole I; Tucker K
Gynecol Oncol; 1999 Oct; 75(1):122-9. PubMed ID: 10502438
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic oophorectomy and ovarian cancer surveillance. Patient perceptions and satisfaction.
Swisher EM; Babb S; Whelan A; Mutch DG; Rader JS
J Reprod Med; 2001 Feb; 46(2):87-94. PubMed ID: 11255821
[TBL] [Abstract][Full Text] [Related]
8. [Primary peritoneal carcinoma: a report of two cases and a review of the literature].
Popovska S; Veselinova T; Gorchev G; Tomov S; Elenchev L
Akush Ginekol (Sofiia); 2005; 44(1):8-10. PubMed ID: 15853004
[TBL] [Abstract][Full Text] [Related]
9. Prevention of ovarian cancer: a survey of the practice of prophylactic oophorectomy by consultant gynaecologists in Ireland.
Geary M; Geoghegan A; Foley M
Ir Med J; 1997; 90(5):186-7. PubMed ID: 9345830
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of normal-sized ovaries associated with primary peritoneal serous carcinoma for possible precursors of ovarian serous carcinoma.
Seidman JD; Wang BG
Gynecol Oncol; 2007 Jul; 106(1):201-6. PubMed ID: 17477958
[TBL] [Abstract][Full Text] [Related]
11. Familial papillary serous carcinoma of the cervix, peritoneum, and ovary: a report of the first case.
Kaplan EJ; Caputo TA; Shen PU; Sassoon RI; Soslow RA
Gynecol Oncol; 1998 Aug; 70(2):289-94. PubMed ID: 9740708
[TBL] [Abstract][Full Text] [Related]
12. Papillary serous carcinoma of the peritoneum following endometrial cancer.
Rose PG; Reale FR
Obstet Gynecol; 1991 Nov; 78(5 Pt 2):980-3. PubMed ID: 1923247
[TBL] [Abstract][Full Text] [Related]
13. Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy.
Lamb JD; Garcia RL; Goff BA; Paley PJ; Swisher EM
Am J Obstet Gynecol; 2006 Jun; 194(6):1702-9. PubMed ID: 16731090
[TBL] [Abstract][Full Text] [Related]
14. Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1/2 mutations: a decision analysis.
Armstrong K; Schwartz JS; Randall T; Rubin SC; Weber B
J Clin Oncol; 2004 Mar; 22(6):1045-54. PubMed ID: 14981106
[TBL] [Abstract][Full Text] [Related]
15. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
[TBL] [Abstract][Full Text] [Related]
16. Papillary peritoneal carcinomatosis after prophylactic oophorectomy.
Kemp GM; Hsiu JG; Andrews MC
Gynecol Oncol; 1992 Dec; 47(3):395-7. PubMed ID: 1473756
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic oophorectomy in inherited breast/ovarian cancer families.
Struewing JP; Watson P; Easton DF; Ponder BA; Lynch HT; Tucker MA
J Natl Cancer Inst Monogr; 1995; (17):33-5. PubMed ID: 8573450
[TBL] [Abstract][Full Text] [Related]
18. Papillary serous carcinoma in ovaries of normal size: a clinicopathologic study of 20 cases and comparison with extraovarian peritoneal papillary serous carcinoma.
Choi CH; Kim TJ; Kim WY; Ahn GH; Lee JW; Kim BG; Lee JH; Bae DS
Gynecol Oncol; 2007 Jun; 105(3):762-8. PubMed ID: 17383715
[TBL] [Abstract][Full Text] [Related]
19. Ovarian dysplasia in prophylactic oophorectomy specimens: cytogenetic and morphometric correlations.
Deligdisch L; Gil J; Kerner H; Wu HS; Beck D; Gershoni-Baruch R
Cancer; 1999 Oct; 86(8):1544-50. PubMed ID: 10526284
[TBL] [Abstract][Full Text] [Related]
20. Malignancies following bilateral salpingo-oophorectomy (BSO).
Gotlieb WH; Barchana M; Ben-Baruch G; Friedman E
Eur J Surg Oncol; 2006 Dec; 32(10):1231-4. PubMed ID: 16626923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
